The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
A Prospective Natural-History Study of Coronary Atherosclerosis
Stone, G. W., Maehara, A., Lansky, A. J., de Bruyne, B., Cristea, E., Mintz, G. S., Mehran, R., McPherson, J., Farhat, N., Marso, S. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1002358 · Cited by 3,276
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Neutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3024 · Cited by 3,027
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Inflammation in Atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.009 · Cited by 2,228
The Pathogenesis of Atherosclerosis: (First of Two Parts)
Ross, R., & Glomset, J. A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608122950707 · Cited by 2,014
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Tschopp, J., & Schroder, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2725 · Cited by 1,850
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536
Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513
The IL-1 family: regulators of immunity
Sims, J. E., & Smith, D. E. (2010) · Nature Reviews Immunology · doi:10.1038/nri2691 · Cited by 1,418
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,334
Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis
Warnatsch, A., Ioannou, M., Wang, Q., & Papayannopoulos, V. (2015) · Science · doi:10.1126/science.aaa8064 · Cited by 1,270
Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme
Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M. A., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., et al. (1997) · Science · doi:10.1126/science.275.5297.206 · Cited by 1,155
Swirski, F. K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R., & Pittet, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29950 · Cited by 1,148
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A., & Thompson, P. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.027 · Cited by 1,054
Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Hansson, G. K., Libby, P., Schönbeck, U., & Yan, Z.-Q. (2002) · Circulation Research · doi:10.1161/01.res.0000029784.15893.10 · Cited by 1,024
Sensing and reacting to microbes through the inflammasomes
Franchi, L., Muñoz-Planillo, R., & Núñez, G. (2012) · Nature Immunology · doi:10.1038/ni.2231 · Cited by 1,012
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 980
Colchicine—Update on mechanisms of action and therapeutic uses
Leung, Y. Y., Yao Hui, L. L., & Kraus, V. B. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.06.013 · Cited by 950
Interleukin-18 and IL-18 Binding Protein
Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00289 · Cited by 938
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Du Pasquier, R. A., Romero, P., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 933
Kawaguchi, M., Takahashi, M., Hata, T., Kashima, Y., Usui, F., Morimoto, H., Izawa, A., Takahashi, Y., Masumoto, J., Koyama, J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.982777 · Cited by 884
Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
Misawa, T., Takahama, M., Kozaki, T., Lee, H., Zou, J., Saitoh, T., & Akira, S. (2013) · Nature Immunology · doi:10.1038/ni.2550 · Cited by 855
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748
Shah, P. K., Falk, E., Badimón, J. J., Fernández‐Ortíz, A., Mailhac, A. C., Villareal-Levy, G., Fallon, J. T., Regnström, J., & Fuster, V. (1995) · PubMed · Cited by 722
Neutrophil Infiltration of Culprit Lesions in Acute Coronary Syndromes
Naruko, T., Ueda, M., Haze, K., van der Wal, A. C., van der Loos, C. M., Itoh, A., Komatsu, R., Ikura, Y., Ogami, M., Shimada, Y., et al. (2002) · Circulation · doi:10.1161/01.cir.0000042674.89762.20 · Cited by 660
IL-33 reduces the development of atherosclerosis
Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., & Liew, F. Y. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071868 · Cited by 642
Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex
Greenfeder, S. A., Nunes, P., Kwee, L., Labow, M., Chizzonite, R. A., & Ju, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13757 · Cited by 639
Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability
Mallat, Z., Corbaz, A., Scoazec, A., Besnard, S., Lesèche, G., Chvatchko, Y., & Tedgui, A. (2001) · Circulation · doi:10.1161/hc3901.096721 · Cited by 636
Platelet Inhibition with Cangrelor in Patients Undergoing PCI
Harrington, R. A., Stone, G. W., McNulty, S., White, H. D., Lincoff, A. M., Gibson, C. M., Pollack, C. V., Montalescot, G., Mahaffey, K. W., Kleiman, N. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908628 · Cited by 625
Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS
Park, Y. H., Wood, G., Kastner, D. L., & Chae, J. J. (2016) · Nature Immunology · doi:10.1038/ni.3457 · Cited by 586
Nuclear Factor κB Signaling in Atherogenesis
de Winther, M. P. J., Kanters, E., Kraal, G., & Hofker, M. H. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160340.72641.87 · Cited by 575
Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina
Blankenberg, S., Tiret, L., Bickel, C., Peetz, D., Cambien, F., Meyer, J., & Rupprecht, H. J. (2002) · Circulation · doi:10.1161/01.cir.0000020546.30940.92 · Cited by 568
Ridker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
IL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
Rider, P., Carmi, Y., Guttman, O., Braiman, A., Cohen, I., Voronov, E., White, M. R., Dinarello, C. A., & Apte, R. N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102048 · Cited by 522
Mangold, A., Alias, S., Scherz, T., Hofbauer, T. M., Jakowitsch, J., Panzenböck, A., Simon, D., Laimer, D., Bangert, C., Kammerlander, A., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.304944 · Cited by 511
Anti‐mitotic activity of colchicine and the structural basis for its interaction with tubulin
Bhattacharyya, B., Panda, D., Gupta, S., & Banerjee, M. (2008) · Medicinal Research Reviews · doi:10.1002/med.20097 · Cited by 499
Multiple Roles for Neutrophils in Atherosclerosis
Soehnlein, O. (2012) · Circulation Research · doi:10.1161/circresaha.111.257535 · Cited by 498
Hypochlorous Acid Oxygenates the Cysteine Switch Domain of Pro-matrilysin (MMP-7)
Fu, X., Kassim, S. Y., Parks, W. C., & Heinecke, J. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106958200 · Cited by 482
Inflammatory cytokines in atherosclerosis: current therapeutic approaches
Tousoulis, D., Oikonomou, E., Economou, E. K., Crea, F., & Kaski, J. C. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv759 · Cited by 460
Podrez, E. A., Febbraio, M., Sheibani, N., Schmitt, D., Silverstein, R. L., Hajjar, D. P., Cohen, P. A., Frazier, W. A., Hoff, H. F., & Hazen, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8574 · Cited by 455
Neutrophil secretion products pave the way for inflammatory monocytes
Soehnlein, O., Zernecke, A., Eriksson, E. E., Rothfuchs, A. G., Pham, C. T., Herwald, H., Bidzhekov, K., Rottenberg, M. E., Weber, C., & Lindbom, L. (2008) · Blood · doi:10.1182/blood-2008-02-139634 · Cited by 436
Elssner, A., Duncan, M., Gavrilin, M., & Wewers, M. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4987 · Cited by 425
Centola, M., Wood, G., Frucht, D. M., Galon, J., Aringer, M., Farrell, C., Kingma, D. W., Horwitz, M. E., Mansfield, E., Holland, S. M., et al. (2000) · Blood · doi:10.1182/blood.v95.10.3223 · Cited by 419
Zernecke, A., Bot, I., Djalali-Talab, Y., Shagdarsuren, E., Bidzhekov, K., Meiler, S., Krohn, R., Schober, A., Sperandio, M., Soehnlein, O., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.160697 · Cited by 417
Abbate, A., Kontos, M. C., Grizzard, J. D., Biondi-Zoccai, G. G. L., Van Tassell, B. W., Robati, R., Roach, L. M., Arena, R. A., Roberts, C. S., Varma, A., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.12.059 · Cited by 415
Cronstein, B. N., Molad, Y., Reibman, J., Balakhane, E., Levin, R. I., & Weissmann, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118147 · Cited by 388
Interleukin-18 Enhances Atherosclerosis in Apolipoprotein E −/− Mice Through Release of Interferon-γ
Whitman, S. C., Ravisankar, P., & Daugherty, A. (2002) · Circulation Research · doi:10.1161/hh0202.105292 · Cited by 385
Monocytes in Coronary Artery Disease and Atherosclerosis
Ghattas, A., Griffiths, H. R., Devitt, A., Lip, G. Y. H., & Shantsila, E. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.043 · Cited by 375
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice
Elhage, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00343-2 · Cited by 373
Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease
Swirski, F. K., Pittet, M. J., Kircher, M. F., Aikawa, E., Jaffer, F. A., Libby, P., & Weissleder, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604260103 · Cited by 367
Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling
Bujak, M., Dobaczewski, M., Chatila, K., Mendoza, L. H., Li, N., Reddy, A., & Frangogiannis, N. G. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070974 · Cited by 365
Morton, A. C., Rothman, A. M. K., Greenwood, J. P., Gunn, J., Chase, A., Clarke, B., Hall, A. S., Fox, K., Foley, C., Banya, W., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu272 · Cited by 353
Dinarello, C., Arend, W., Sims, J., Smith, D., Blumberg, H., O'Neill, L., Goldbach-Mansky, R., Pizarro, T., Hoffman, H., Bufler, P., et al. (2010) · Nature Immunology · doi:10.1038/ni1110-973 · Cited by 351
van der Heijden, T., Kritikou, E., Venema, W., van Duijn, J., van Santbrink, P. J., Slütter, B., Foks, A. C., Bot, I., & Kuiper, J. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309575 · Cited by 348
Molecular mechanisms involved in inflammasome activation
Bryant, C., & Fitzgerald, K. A. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.06.002 · Cited by 347
Inflammasomes: too big to miss
Stutz, A., Golenbock, D. T., & Latz, E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40599 · Cited by 346
Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity
Brydges, S. D., Mueller, J. L., McGeough, M. D., Pena, C. A., Misaghi, A., Gandhi, C., Putnam, C. D., Boyle, D. L., Firestein, G. S., Horner, A. A., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.005 · Cited by 339
Macrophage roles following myocardial infarction
Lambert, J. M., Lopez, E. F., & Lindsey, M. L. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.04.059 · Cited by 339
Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease
Galea, J., Armstrong, J., Gadsdon, P., Holden, H., Francis, S. E., & Holt, C. M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.1000 · Cited by 310
Pomerantz, B. J., Reznikov, L. L., Harken, A. H., & Dinarello, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041611398 · Cited by 310
Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome
Vaidya, K., Arnott, C., Martínez, G. J., Ng, B., McCormack, S., Sullivan, D. R., Celermajer, D. S., & Patel, S. (2018) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2017.08.013 · Cited by 300
Self-citationNiel, E., & Scherrmann, J.-M. (2006) · Joint Bone Spine · doi:10.1016/j.jbspin.2006.03.006 · Cited by 286
Martínez, G. J., Robertson, S., Barraclough, J., Xia, Q., Mallat, Z., Bursill, C., Celermajer, D. S., & Patel, S. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002128 · Cited by 283
Self-citationAnti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study
Deftereos, S., Giannopoulos, G., Angelidis, C., Alexopoulos, N., Filippatos, G., Papoutsidakis, N., Sianos, G., Goudevenos, J., Alexopoulos, D., Pyrgakis, V., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.017611 · Cited by 279
Metalloproteinases and Vulnerable Atherosclerotic Plaques
Newby, A. C. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.09.001 · Cited by 253
Malle, E., Waeg, G., Schreiber, R., Gröne, E. F., Sattler, W., & Gröne, H. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01498.x · Cited by 245
Tiret, L., Godefroy, T., Lubos, E., Nicaud, V., Tregouet, D.-A., Barbaux, S., Schnabel, R., Bickel, C., Espinola-Klein, C., Poirier, O., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.519702 · Cited by 229
CRITTENDEN, D. B., LEHMANN, R. A., SCHNECK, L., KEENAN, R. T., SHAH, B., GREENBERG, J. D., CRONSTEIN, B. N., SEDLIS, S. P., & PILLINGER, M. H. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111533 · Cited by 222
Chang, Y.-P., Ka, S.-M., Hsu, W.-H., Chen, A., Chao, L. K., Lin, C.-C., Hsieh, C.-C., Chen, M.-C., Chiu, H.-W., Ho, C.-L., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24903 · Cited by 216
Update on colchicine and its mechanism of action
Molad, Y. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0073-2 · Cited by 213
The role of interleukin‐1 and the inflammasome in gout: Implications for therapy
Pope, R. M., & Tschopp, J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22938 · Cited by 207
Nidorf, M., & Thompson, P. L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.10.039 · Cited by 201
Physiological Concentrations of K+ Inhibit Cytochrome c-dependent Formation of the Apoptosome
Cain, K., Langlais, C., Sun, X.-M., Brown, D. G., & Cohen, G. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107419200 · Cited by 197
Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR −/− Mice
van Leeuwen, M., Gijbels, M. J. J., Duijvestijn, A., Smook, M., van de Gaar, M. J., Heeringa, P., de Winther, M. P. J., & Tervaert, J. W. C. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.154807 · Cited by 196
Wang, X., Feuerstein, G. Z., Gu, J.-L., Lysko, P. G., & Yue, T.-L. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05503-b · Cited by 195
Van Gorp, H., Saavedra, P. H. V., de Vasconcelos, N. M., Van Opdenbosch, N., Vande Walle, L., Matusiak, M., Prencipe, G., Insalaco, A., Van Hauwermeiren, F., Demon, D., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613156113 · Cited by 185
Abderrazak, A., Couchie, D., Mahmood, D. F. D., Elhage, R., Vindis, C., Laffargue, M., Matéo, V., Büchele, B., Ayala, M. R., El Gaafary, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013730 · Cited by 176
Novel biomarkers in cardiovascular disease: Update 2010
Hochholzer, W., Morrow, D. A., & Giugliano, R. P. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.06.010 · Cited by 174
Chi, H., Messas, E., Levine, R. A., Graves, D. T., & Amar, S. (2004) · Circulation · doi:10.1161/01.cir.0000142085.39015.31 · Cited by 173
Role of polymorphonuclear neutrophils in atherosclerosis: Current state and future perspectives
Baetta, R., & Corsini, A. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.028 · Cited by 170
Abbate, A., Kontos, M. C., Abouzaki, N. A., Melchior, R. D., Thomas, C., Van Tassell, B. W., Oddi, C., Carbone, S., Trankle, C. R., Roberts, C. S., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.11.003 · Cited by 160
Robertson, S., Martínez, G. J., Payet, C. A., Barraclough, J. Y., Celermajer, D. S., Bursill, C., & Patel, S. (2016) · Clinical Science · doi:10.1042/cs20160090 · Cited by 160
Self-citationRider, P., Carmi, Y., Voronov, E., & Apte, R. N. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.005 · Cited by 155
Marques-da-Silva, C., Chaves, M. M., Castro, N. G., Coutinho‐Silva, R., & Guimaraes, M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01254.x · Cited by 154
Colchicine intoxication: Clinical pharmacology, risk factors, features, and management
Putterman, C., Ben‐Chetrit, E., Caraco, Y., & Levy, M. (1991) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(91)90003-i · Cited by 153
Fujisue, K., Sugamura, K., Kurokawa, H., Matsubara, J., Ishii, M., Izumiya, Y., Kaikita, K., & Sugiyama, S. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-0949 · Cited by 148
† (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00034-0 · Cited by 143
Novel anti-inflammatory therapies for the treatment of atherosclerosis
Khan, R., Spagnoli, V., Tardif, J., & L’Allier, P. L. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.783 · Cited by 139
Cutting Edge: Necrosis Activates the NLRP3 Inflammasome
Li, H., Ambade, A., & Re, F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901080 · Cited by 137
Shao, B., Wei, W., Ke, P., Xu, Z., Zhou, J., & Liu, C. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12349 · Cited by 135
Akodad, M., Lattuca, B., Nagot, N., Georgescu, V., Buisson, M., Cristol, J., Leclercq, F., Macia, J., Gervasoni, R., Cung, T.-T., et al. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2016.10.004 · Cited by 130
Raju, N. C., Yi, Q., Nidorf, M., Fagel, N. D., Hiralal, R., & Eikelboom, J. W. (2011) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0637-y · Cited by 129
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis
Malhotra, S., Río, J., Urcelay, E., Nurtdinov, R., Bustamante, M. F., Fernández, Ó., Oliver‐Martos, B., Zettl, U. K., Brassat, D., Killestein, J., et al. (2015) · Brain · doi:10.1093/brain/awu388 · Cited by 129
Interleukin 18 and coronary heart disease: Prospective study and systematic review
Jefferis, B. J. M. H., Papacosta, O., Owen, C. G., Wannamethee, S. G., Humphries, S. E., Woodward, M., LENNON, L. T., Thomson, A. G., Welsh, P. I., Rumley, A., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.015 · Cited by 128
Zirlik, A., Abdullah, S. M., Gerdes, N., MacFarlane, L. A., Schönbeck, U., Khera, A., McGuire, D. K., Vega, G. L., Grundy, S. M., Libby, P., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149484 · Cited by 122
Lim, R. S., Suhalim, J. L., Miyazaki‐Anzai, S., Miyazaki, M., Levi, M., Potma, E. O., & Tromberg, B. J. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m018077 · Cited by 116
Yajima, N., Takahashi, M., Morimoto, H., Shiba, Y., Takahashi, Y., Masumoto, J., Ise, H., Sagara, J., Nakayama, J., Taniguchi, S., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.746453 · Cited by 104
Mazor, R., Shurtz-Swirski, R., Farah, R. E., Kristal, B., Shapiro, G., Dorlechter, F., Cohen-Mazor, M., Meilin, E., Snitkovsky, T., & Sela, S. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.08.014 · Cited by 102
Human neutrophil elastase: Mediator and therapeutic target in atherosclerosis
Henriksen, P. A., & Sallenave, J. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.01.004 · Cited by 94
Band neutrophil count and the presence and severity of coronary atherosclerosis
Kawaguchi, H., Mori, T., Kawano, T., Kono, S., Sasaki, J., & Arakawa, K. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90384-1 · Cited by 93
Tassell, B. W. V., Varma, A., Salloum, F. N., Das, A., Seropian, I. M., Toldo, S. A., Smithson, L. A., Hoke, N. N., Chau, V. Q., Robati, R., et al. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181c87e53 · Cited by 84
Akodad, M., Fauconnier, J., Sicard, P., Huet, F., Blandel, F., Bourret, A., Barbara, P. D. S., Aguilhon, S., Gall, M. L., Hugon, G., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.126 · Cited by 84
Altaf, A., Qu, P., Zhao, Y., Wang, H., Lou, D., & Niu, N. (2015) · Coronary Artery Disease · doi:10.1097/mca.0000000000000255 · Cited by 80
Torzewski, M., Dahm, M., Kirkpatrick, C. J., Lackner, K. J., Vahl, C., & Dorweiler, B. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-06-0387 · Cited by 74
Otani, K., Watanabe, T., Shimada, S., Takeda, S., Itani, S., Higashimori, A., Nadatani, Y., Nagami, Y., Tanaka, F., Kamata, N., et al. (2016) · Scientific Reports · doi:10.1038/srep32587 · Cited by 71
Hemkens, L. G., Ewald, H., Gloy, V., Arpagaus, A., Olu, K. K., Nidorf, M., Glinz, D., Nordmann, A. J., & Briel, M. (2016) · Heart · doi:10.1136/heartjnl-2015-308542 · Cited by 62
Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica
Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M., Corrà, U., Cosyns, B., Deaton, C., Graham, I., et al. (2016) · Revista Española de Cardiología · doi:10.1016/j.recesp.2016.09.004 · Cited by 59
Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia
Huang, C., Cen, C., Wang, C., Zhan, H., & Ding, X. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-67 · Cited by 56
Nidorf, S. M., Eikelboom, J. W., & Thompson, P. L. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413499972 · Cited by 49
Γιαννόπουλος, Γ., Angelidis, C., Kouritas, V. K., Dedeilias, P., Filippatos, G. S., CLEMAN, M. W., Panagopoulou, V., Siasos, G., Tousoulis, D. M., Lekakis, J. P., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.02.036 · Cited by 46
Pezzato, E., Donà, M., Sartor, L., Dell’Aica, I., Benelli, R., Albini, A., & Garbisa, S. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0203086 · Cited by 40
Rotzius, P., Soehnlein, O., Kenne, E. M., Lindbom, L., Nystrom, K., Thams, S., & Eriksson, E. E. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.009 · Cited by 34
Binding of colchicine and thiocolchicoside to human serum proteins and blood cells.
Sabouraud, A. E., Chappey, O., Dupin, T., & Scherrmann, J. (1994) · PubMed · Cited by 33
Making a difference. The World Health Report 1999.
(1999) · PubMed · Cited by 31
Haplotypes of the Caspase-1 Gene, Plasma Caspase-1 Levels, and Cardiovascular Risk
Blankenberg, S., Godefroy, T., Poirier, O., Rupprecht, H. J., Barbaux, S., Bickel, C., Nicaud, V., Schnabel, R. B., Kee, F., Morrison, C. E., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000232324.87983.4b · Cited by 27
Interleukin-1β induces endothelin-1 gene by multiple mechanisms
Herman, W. H., Holcomb, J., Hricik, D. E., & Simonson, M. S. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)02109-5 · Cited by 18
Cited by
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183
“Previous clinical and experimental studies have demonstrated that IL-1β, as a proatherogenic cytokine, is involved in atherosclerosis progression, suggesting that NLRP3 inflammasome is presumably a key element in atherosclerotic pathogenesis.(153,184) Indeed, the expression of NLRP3 inflammasome is increased in the pl…”
ResultTargeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation
Marchio, P., Guerra-Ojeda, S., Vila, J. M., Aldasoro, M., Victor, V. M., & Mauricio, M. D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8563845 · Cited by 621
Myocardial ischemia-reperfusion injury and the influence of inflammation
Algoet, M., Janssens, S., Himmelreich, U., Gsell, W., Pusovnik, M., Van den Eynde, J., & Oosterlinck, W. (2023) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.02.005 · Cited by 545
Inflammation and cardiovascular disease: From mechanisms to therapeutics
Alfaddagh, A., Martin, S. S., Leucker, T. M., Michos, E. D., Blaha, M. J., Lowenstein, C. J., Jones, S. R., & Toth, P. P. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100130 · Cited by 473
Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial
Tong, D. C., Quinn, S., Nasis, A., Hiew, C., Roberts-Thomson, P., Adams, H., Sriamareswaran, R., Htun, N. M., Wilson, W., Stub, D., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.050771 · Cited by 393
Metadata
- Authors
- Martínez, G. J., Celermajer, D. S., & Patel, S.
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 269
- Pages
- 262-271
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W2780415304
- Cited by
- 342
- References
- 130
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.